Articles by University of Cambridge

The study identified several drugs already licensed and in use that have the potential to be repurposed to treat dementia.

High levels of IFN-γ persisted in some long COVID patients for up to 31 months, making it a reliable biomarker

Per the first author, "the reactome could change the way we think about organic chemistry."

Discovery opens the door to treatments for multiple sclerosis-associated long-term disability 

Using DNA as "bait" to detect respiratory viruses with highly accurate results

The findings could improve screening and help with clinical trial recruitment

Researchers say a “human bottleneck,” delayed the UK’s scale-up of COVID-19 testing

There is little to no evidence of a link between urinary symptoms and prostate cancer

Researchers hope that this work helps improve the targeting of assessments and interventions

Whole Genome Sequencing picks up 31 percent more cases of rare genetic disorders than standard tests

The new cancer treatment targets enzymes that play a key role in translating DNA into proteins

The algorithm makes it possible to identify a tumor's weakness in order to personalize cancer therapy

Researchers show how a new technique known as hyperpolarization can be used to monitor how effective cancer drugs are at slowing a tumor's growth

The model resembles some key elements of an embryo at around 18-21 days old and allows researchers to observe the processes underlying the formation of the human blueprint

The lack of methods to detect oligomers has been a major obstacle in the progress of Alzheimer's research